课题基金 / 基金详情

The Biomimetic Synthesis of (-)-Kaur-16-en-19-oic Acid

The Biomimetic Synthesis of (-)-Kaur-16-en-19-oic Acid
(-)-Kaur-16-en-19-oic 酸的仿生合成
批准号:
6625999
负责人:
RANDALL W VIVIAN
金额:
$4.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
未结题
起止时间:
2002-07-01 至

项目摘要

项目成果

RANDALL W VIVIAN的其他基金

相似基金

相关文献

中文摘要
翻译
(-)-Kaur-16-en-19 OIC酸的仿生全合成将通过阳离子烯烃多环化反应进行对映选择性的尝试。手性将通过夏普莱斯不对称环氧化反应生成对映体选择性环氧化物来引入。关键反应将在单一的协同反应步骤中同时产生三个碳环和五个连续的立体中心,并有望在产物分子中产生高的对映选择性。该靶标是一种天然产品,具有类似于赤霉素的生物活性,赤霉素是一种植物生长激素。它通常与赤霉素一起从各种植物中分离出来,可能是赤霉素生物合成的中间体。建议的合成通过立体选择性策略在已发表的合成的基础上进行改进,这将支持目标化合物的成功合成。预计该提案的成功完成将有助于开发一种通用的获取方法,该方法可用于与具有更显著(即抗微生物、杀锥虫和抗艾滋病毒)生物活性的(-)-Kaur-16-en-19-OIC酸相关的其他二萜类天然产物目标。
英文摘要
The biomimetic total synthesis of (-)-kaur-16-en-19 oic acid will be attempted enantioselectively via a cation olefin polyannulation reaction. Chirality will be introduced by enantioselective epoxide formation via Sharpless asymmetric epoxidation. The key reaction will create three carbocycles and five contiguous stereocenters simultaneously in a single concerted reaction step and is expected to produce high enantioselectivities in the product molecule. The target is a natural product that has biological activity similar to gibberelines a plant growth hormone. It is often isolated from various plant species along with gibberellines, and may be an intermediate in gibberellin biosynthesis. The proposed synthesis improves upon published synthesis by Stereoselective strategies that will support a successful synthesis of the target compound. It is anticipated that a successful completion of the proposal will allow for the development of a general method of access that is modifiable for other diterpenoid natural product targets related to (-)-kaur-16-en-19-oic acid that possess more significant (i.e. anti- microbial, trypansomicidal and anti-HIV) biological activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Biomimetic Synthesis of (-)-Kaur-16-en-19-oic Acid
  • 批准号:
    6483724
  • 项目类别:
  • 资助金额:
    $3.66万
  • 财政年份:
    2002
  • 负责人:
    RANDALL W VIVIAN
  • 依托单位:
海外基金